Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies

The epidermal growth factor receptor (EGFR) has been recognized as an important therapeutic target in oncology. It is commonly overexpressed in a variety of solid tumors and is critically involved in cell survival, proliferation, metastasis, and angiogenesis. This multi-dimensional role of EGFR in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Biteghe, Fleury Augustin Nsole, Mungra, Neelakshi, Chalomie, Nyangone Ekome Toung, Ndong, Jean De La Croix, Engohang-Ndong, Jean, Vignaux, Guillaume, Padayachee, Eden, Naran, Krupa, Barth, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517958/
https://www.ncbi.nlm.nih.gov/pubmed/33014289
http://dx.doi.org/10.18632/oncotarget.27730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517958/
https://www.ncbi.nlm.nih.gov/pubmed/33014289
http://dx.doi.org/10.18632/oncotarget.27730

Ejemplares similares